Aluminum toxicity in patients undergoing dialysis: Radiographic findings and prediction of bone biopsy results

J. C. Kriegshauser, R. G. Swee, J. T. McCarthy, M. F. Hauser

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Aluminum toxicity in patients undergoing dialysis currently requires bone biopsy for definitive diagnosis. The authors retrospectively reviewed clinical, histologic, and radiographic findings in 63 patients undergoing dialysis. In 30 patients, biopsy specimens were negative for aluminum toxicity, and in 33 patients, specimens were positive. In 21 of the 30 patients who had a negative biopsy specimen, absence of aluminum toxicity could be predicted by a high immunoreactive parathyroid hormone level (>2,000 μlEq/ml [2,210 pM]) and fewer than three fractures, by the presence of osteosclerosis on radiographs, or if serum aluminum levels were less than 30 ng/ml. None of the patients who had a positive biopsy specimen met these criteria. In 18 of 33 patients who had a positive biopsy specimen, aluminum toxicity could be predicted by a low immunoreactive parathyroid hormone level (<500 μlEq/ml [553 pM]) and more than three fractures, or if serum aluminum levels were greater than 300 ng/ml. None of the patients who had a negative biopsy specimen met these criteria. Thus, based on the criteria identified, the aluminum status of 62% of these patients would have been correctly diagnosed.

Original languageEnglish (US)
Pages (from-to)399-403
Number of pages5
JournalRadiology
Volume164
Issue number2
StatePublished - 1987

Fingerprint

Aluminum
Dialysis
Biopsy
Bone and Bones
Parathyroid Hormone
Osteosclerosis
Serum

ASJC Scopus subject areas

  • Radiological and Ultrasound Technology

Cite this

Kriegshauser, J. C., Swee, R. G., McCarthy, J. T., & Hauser, M. F. (1987). Aluminum toxicity in patients undergoing dialysis: Radiographic findings and prediction of bone biopsy results. Radiology, 164(2), 399-403.

Aluminum toxicity in patients undergoing dialysis : Radiographic findings and prediction of bone biopsy results. / Kriegshauser, J. C.; Swee, R. G.; McCarthy, J. T.; Hauser, M. F.

In: Radiology, Vol. 164, No. 2, 1987, p. 399-403.

Research output: Contribution to journalArticle

Kriegshauser, JC, Swee, RG, McCarthy, JT & Hauser, MF 1987, 'Aluminum toxicity in patients undergoing dialysis: Radiographic findings and prediction of bone biopsy results', Radiology, vol. 164, no. 2, pp. 399-403.
Kriegshauser, J. C. ; Swee, R. G. ; McCarthy, J. T. ; Hauser, M. F. / Aluminum toxicity in patients undergoing dialysis : Radiographic findings and prediction of bone biopsy results. In: Radiology. 1987 ; Vol. 164, No. 2. pp. 399-403.
@article{ea8b46b02d27417abd86ddcef6eed2bd,
title = "Aluminum toxicity in patients undergoing dialysis: Radiographic findings and prediction of bone biopsy results",
abstract = "Aluminum toxicity in patients undergoing dialysis currently requires bone biopsy for definitive diagnosis. The authors retrospectively reviewed clinical, histologic, and radiographic findings in 63 patients undergoing dialysis. In 30 patients, biopsy specimens were negative for aluminum toxicity, and in 33 patients, specimens were positive. In 21 of the 30 patients who had a negative biopsy specimen, absence of aluminum toxicity could be predicted by a high immunoreactive parathyroid hormone level (>2,000 μlEq/ml [2,210 pM]) and fewer than three fractures, by the presence of osteosclerosis on radiographs, or if serum aluminum levels were less than 30 ng/ml. None of the patients who had a positive biopsy specimen met these criteria. In 18 of 33 patients who had a positive biopsy specimen, aluminum toxicity could be predicted by a low immunoreactive parathyroid hormone level (<500 μlEq/ml [553 pM]) and more than three fractures, or if serum aluminum levels were greater than 300 ng/ml. None of the patients who had a negative biopsy specimen met these criteria. Thus, based on the criteria identified, the aluminum status of 62{\%} of these patients would have been correctly diagnosed.",
author = "Kriegshauser, {J. C.} and Swee, {R. G.} and McCarthy, {J. T.} and Hauser, {M. F.}",
year = "1987",
language = "English (US)",
volume = "164",
pages = "399--403",
journal = "Radiology",
issn = "0033-8419",
publisher = "Radiological Society of North America Inc.",
number = "2",

}

TY - JOUR

T1 - Aluminum toxicity in patients undergoing dialysis

T2 - Radiographic findings and prediction of bone biopsy results

AU - Kriegshauser, J. C.

AU - Swee, R. G.

AU - McCarthy, J. T.

AU - Hauser, M. F.

PY - 1987

Y1 - 1987

N2 - Aluminum toxicity in patients undergoing dialysis currently requires bone biopsy for definitive diagnosis. The authors retrospectively reviewed clinical, histologic, and radiographic findings in 63 patients undergoing dialysis. In 30 patients, biopsy specimens were negative for aluminum toxicity, and in 33 patients, specimens were positive. In 21 of the 30 patients who had a negative biopsy specimen, absence of aluminum toxicity could be predicted by a high immunoreactive parathyroid hormone level (>2,000 μlEq/ml [2,210 pM]) and fewer than three fractures, by the presence of osteosclerosis on radiographs, or if serum aluminum levels were less than 30 ng/ml. None of the patients who had a positive biopsy specimen met these criteria. In 18 of 33 patients who had a positive biopsy specimen, aluminum toxicity could be predicted by a low immunoreactive parathyroid hormone level (<500 μlEq/ml [553 pM]) and more than three fractures, or if serum aluminum levels were greater than 300 ng/ml. None of the patients who had a negative biopsy specimen met these criteria. Thus, based on the criteria identified, the aluminum status of 62% of these patients would have been correctly diagnosed.

AB - Aluminum toxicity in patients undergoing dialysis currently requires bone biopsy for definitive diagnosis. The authors retrospectively reviewed clinical, histologic, and radiographic findings in 63 patients undergoing dialysis. In 30 patients, biopsy specimens were negative for aluminum toxicity, and in 33 patients, specimens were positive. In 21 of the 30 patients who had a negative biopsy specimen, absence of aluminum toxicity could be predicted by a high immunoreactive parathyroid hormone level (>2,000 μlEq/ml [2,210 pM]) and fewer than three fractures, by the presence of osteosclerosis on radiographs, or if serum aluminum levels were less than 30 ng/ml. None of the patients who had a positive biopsy specimen met these criteria. In 18 of 33 patients who had a positive biopsy specimen, aluminum toxicity could be predicted by a low immunoreactive parathyroid hormone level (<500 μlEq/ml [553 pM]) and more than three fractures, or if serum aluminum levels were greater than 300 ng/ml. None of the patients who had a negative biopsy specimen met these criteria. Thus, based on the criteria identified, the aluminum status of 62% of these patients would have been correctly diagnosed.

UR - http://www.scopus.com/inward/record.url?scp=0023218446&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0023218446&partnerID=8YFLogxK

M3 - Article

C2 - 3602376

AN - SCOPUS:0023218446

VL - 164

SP - 399

EP - 403

JO - Radiology

JF - Radiology

SN - 0033-8419

IS - 2

ER -